A Shared-Value Model for Enhancing Diabetes Care in South Africa

By Rene Pretorius

April 4, 2025

diabetes care South Africa

Summary

In a world where diabetes management demands both innovation and integration, DiaCision is at the forefront, using AI-driven insights to improve outcomes and reshape the way care is delivered. As we look for transformative models that go beyond traditional approaches, the article “Improving Diabetes Care in South Africa Through a Shared-Value Model” offers an important case study.

This piece reviews a program by Discovery Health, launched in 2021, that aims to enhance diabetes care in South Africa through a shared-value approach. By focusing on improving hemoglobin A1c testing rates, glycemic control, and disease stability, the program has demonstrated measurable success over three years. Notably, it has also contributed to reduced hospital admissions and healthcare costs. In the broader context of advancing diabetes care, this model presents a compelling example of how aligning patient outcomes with system-wide value can lead to scalable, sustainable impact.

Key Insights

  • Shared-Value Model: The program incentivizes medical practitioners to improve diabetes care, leading to better patient outcomes.
  • Glycemic Control and Stability: HbA1c testing rates, glycemic control, and disease stability improved notably.
  • Economic Benefits: Hospital admissions and healthcare costs decreased, suggesting long-term savings.

Background Context

Diabetes is a major global health challenge. The WHO highlights its rising prevalence and the need for effective management. In South Africa, healthcare access varies. Shared-value programs can help bridge gaps in diabetes care in South Africa. The WHO stresses cost-effective interventions that prioritize patient outcomes, aligning with shared-value models.

Implications

This shared-value model has significant implications:

  • Healthcare Cost Reduction: Better diabetes management reduces admissions and costs.
  • Improved Patient Outcomes: Enhanced glycemic control and stability reduce complications and improve quality of life.
  • Scalability and Adaptability: Such programs can inspire similar initiatives elsewhere, aiding broader healthcare reform.

The content highlights innovative healthcare models’ role in improving patient outcomes. Insights from value-based care discussions suggest these models are key to better health outcomes and cost control. For more details, see the original article here.

Reference url

Recent Posts

Portugal health spending 2025
Portugal Health Spending 2025 Reaches Record €4.417 Billion Amid Rising Demand

By João L. Carapinha

May 22, 2026

Portugal health spending 2025 hit a fresh peak as the country’s publicly funded National Health Service recorded its highest annual outlay on medicines, reaching €4.417 billion according to Infarmed data. This total, already net of industry rebates and contributions, was propelled chiefly by expa...
substandard medicines south africa
Substandard Medicines in South Africa: Regulatory Challenges and Economic Implications

By HEOR Staff Writer

May 21, 2026

Substandard medicines in South Africa continue to infiltrate supply chains through informal markets, unlicensed outlets, and online platforms, leaving patients exposed to unregulated weight-loss injections amid stock shortages and high costs for approved options such as Ozempic. Comp...
Strategic Purchasing Healthcare
Transforming Healthcare Value: Strategic Purchasing in South Africa

By João L. Carapinha

May 20, 2026

Strategic Purchasing Healthcare offers a pathway for South Africa’s healthcare system to deliver improved patient outcomes amid constrained resources, where traditional passive purchasing models relying on historical budgets or uncapped fee-for-service payments have fallen short in prioritising e...